Skip to content
Screener

Boston Scientific BSX Finance Lease Liabilities

Discontinued — last reported Q4 '25

Finance Lease Liabilities at other companies

CONMED logo
CONMEDCNMD
$901K-42.2%
Globus Medical logo
Globus MedicalGMED
$398K+54.9%
AngioDynamics logo
AngioDynamicsANGO
$5.4M-6.9%
AtriCure logo
AtriCureATRC
$5.27M-20.6%
Medtronic logo
MedtronicMDT
$54M+3.8%

Other financials

Income statement

See full
Revenue$5.4B+7.5%
Gross profit$3.8B+12.4%
Operating income$1.2B+43.8%
Net income$907.0M+14.1%
EPS (diluted)$0.61+15.1%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total debt$659.0M-94.1%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.3%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$69.46B-56.1%
P/E18.9×-44.4×
P/S3.3×-5.3×

Profitability

See full
Gross margin69.9%+1.7pp
Operating margin19.8%+2.8pp
Net margin17.5%+4.0pp
FCF margin16.9%-0.3pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity0×-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.

The source filing: Boston Scientific’s 10-K, filed February 17, 2026. Open the filing →

Filed
Feb 17, 2026, 4:08 PM EST
Fiscal year
FY2025
Accession
0000885725-26-000010

FAQ

What is Boston Scientific's finance lease liabilities?
Boston Scientific (BSX) reported finance lease liabilities of $122M in Q4 2025.
What does finance lease liabilities mean?
Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.

Ask your AI about Boston Scientific's finance lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude